Barclays’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Buy |
|
|||||
|
2025
Q1 | $3.46M | Buy |
|
|||||
|
2024
Q4 | $2.87M | Buy |
|
|||||
|
2024
Q3 | $3.1M | Buy |
|
|||||
|
2024
Q2 | $1.5M | Buy |
|
|||||
|
2024
Q1 | $1.74M | Buy |
|
|||||
|
2023
Q4 | $979K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $0 | Hold |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Hold |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $233K | Buy |
|
|||||
|
2021
Q3 | $131K | Buy |
|
|||||
|
2021
Q2 | $40K | Sell |
|
|||||
|
2021
Q1 | $301K | Buy |
|
|||||
|
2020
Q4 | $116K | Sell |
|
|||||
|
2020
Q3 | $139K | Sell |
|
|||||
|
2020
Q2 | $213K | Buy |
|
|||||
|
2020
Q1 | $41K | Sell |
|
|||||
|
2019
Q4 | $202K | Buy |
|
|||||
|
2019
Q3 | $105K | Sell |
|
|||||
|
2019
Q2 | $118K | Buy |
|
|||||
|
2019
Q1 | $100K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $59K | Buy |
|
|||||
|
2018
Q2 | $13K | Sell |
|
|||||
|
2018
Q1 | $32K | Buy |
|